Omalizumab for chronic urticaria in children younger than 12 yearsTaha Al‐Shaikhly, Daniel Petroni, Jamie A. Rosenthal et al.|Annals of Allergy Asthma & Immunology|2019Cited by 34
Use of omalizumab for management of idiopathic anaphylaxisLauren W. Kaminsky, Taha Al‐Shaikhly, Daniel Petroni et al.|Annals of Allergy Asthma & Immunology|2021Cited by 27
Extracellular vesicle microRNAs as predictors of response to omalizumab in chronic spontaneous urticariaTaha Al‐Shaikhly, William R. Henderson, James W. MacDonald et al.|Allergy|2020Cited by 7